Millie Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$3.61M Sell
19,027
-212
-1% -$40.6K 3.03% 9
2017
Q3
$3.64M Buy
19,239
+90
+0.5% +$16.3K 2.97% 11
2017
Q2
$3.34M Buy
19,149
+75
+0.4% +$12.6K 2.9% 11
2017
Q1
$2.93M Buy
19,074
+138
+0.7% +$21.1K 2.78% 10
2016
Q4
$2.67M Buy
18,936
+14
+0.1% +$2.06K 2.72% 9
2016
Q3
$3.01M Buy
+18,922
New +$2.92M 3.32% 5

Other funds holding TMO

Millie Capital Management's TMO Position: Q4 2017 in Review

Millie Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 1.1% in Q4 2017, selling an estimated $40.6K and leaving 19,027 shares worth $3.61M. The position accounts for 3.03% of the portfolio, ranked #9.

Millie Capital Management first reported a position in TMO in Q3 2016 and has held it in 6 quarters since. The position peaked at $3.64M in Q3 2017. 1,246 funds tracked by Wall St. Rank hold TMO as of Q4 2017.

  • Millie Capital Management held 19,027 shares of Thermo Fisher Scientific worth $3.61M as of Q4 2017.
  • Millie Capital Management sold 212 Thermo Fisher Scientific shares in Q4 2017, an estimated $40.6K.
  • Thermo Fisher Scientific made up 3.03% of Millie Capital Management's portfolio in Q4 2017, its #9 holding.
  • Millie Capital Management first reported a position in Thermo Fisher Scientific in Q3 2016 and has held it in 6 quarters since.
  • Millie Capital Management's Thermo Fisher Scientific position peaked at $3.64M in Q3 2017.
  • 1,246 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2017.

Based on Millie Capital Management's 13F filing for Q4 2017, filed 7 Feb 2018.